Latest
05
Dec
Fund of the week: Oberland Capital
In my November 25 post, I discussed "Royalties as a Credit Derivative," exploring how creative financing can extend
17 min read
04
Dec
Company of the Week: Dayra Therapeutics
Dayra Therapeutics is a Toronto-based biotech company developing oral macrocyclic peptide drugs for immunological diseases. The company launched in November
8 min read
03
Dec
Insuring Pharmaceutical Royalty Risks: Reinsurance and Case Studies
The pharmaceutical royalty market has grown at a 45% CAGR since 2018, reaching over $6 billion in annual transaction volume—
32 min read
02
Dec
The CFO's Complete Guide to Pharmaceutical Royalty Financing: From Preclinical to Commercial
A stage-by-stage decision framework for evaluating synthetic royalties, royalty monetization, and alternatives in the $29 billion royalty financing market
Pharmaceutical
12 min read
01
Dec
The Annuity Trap: Valuing Gene Therapy Royalties When Cash Flows Are Conditional
How outcome-based payment models are forcing royalty investors to rethink fundamental valuation assumptions—and what the early data reveals
High-cost
18 min read
30
Nov
The Weekly Term Sheet (48)
Biotech Transactions: November 23-29, 2025
GE HealthCare's $2.3 billion acquisition of Intelerad dominated a shortened Thanksgiving week
9 min read
29
Nov
China's clinical trial paradox: massive volume growth masks declining quality and FDA skepticism
Despite a 73% collapse in venture funding from $15.7B (2021) to $4.2B (2024), China's clinical trial
30 min read
28
Nov
Fund of the week: RA Capital Management
RA Capital Management, the $12.6 billion biotech-focused investment firm founded in 2001, has aggressively expanded beyond its equity roots
18 min read
27
Nov
Company of the week: Hanmi Pharm (South Korea)
Company Overview
Hanmi Pharm Co. is one of South Korea's leading pharmaceutical companies, distinguished by its heavy investment
11 min read
26
Nov
Japan's Biotech and Pharma Industry in 2025: Market Overview and Key Players
Introduction: A New Era for Japanese Pharmaceutical Innovation
Japan's pharmaceutical landscape is undergoing a profound transformation. No longer
38 min read